top of page
DOCUMENTATION

     The following diagram shows how SARS-CoV-2 is passed from person to person through respiratory droplets. Once inside the body the virus will invade our cells and reproduce itself. In response to the virus our immune system will attack the invader launching first a response from T-cells designed to kill the cells infected with the virus and later an antibody response designed to kill the virus before it gets into another cell.

 

     This diagram also shows how too much of a good thing can cause harm to the body. When our VIRAL immune response, either because of other health problems we have (comorbidities) produce too much response OR because there is too much of the virus (e.g. vaccines) in our body; the outcome is INFLAMMATION and BLOOD CLOTTING [InflammoThrombotic Response – ITR] that can kill us (COVID-19).

 

     The document numbers listed on the diagram below match the numbered documents providing links to the research as well as other materials not only explaining these issues but also the Gain-of-Function (GoF) research responsible for the development of this man-made virus.

Figure 8(b).png
SARS-CoV-2: Documents 17, 20. 144, 145, 146, 147, 148, 153, 156, 163, 164, 165, 169, 170, 182, 193, 194, 199, 209, 210, 212, 213, 214, 218, 219, 220, 221, 222, 224, 225, 233, 242, 250, 251, 253, 254, 255, 256, 263, 264, 265, 269, 280, 283, 286, 292, 296, 297, 298, 299, 301, 325, 327, 328, 330, 331, 332, 333, 334, 335, 338, 342, 343, 349, 350, 351, 353, 354, 362, 368, 375, 382, 383, 403, 405, 417, 418, 419, 425, 433, 443, 450, 473, 476, 480, 495, 499, 502, 503, 513.

Fleming InflammoThrombotic Response (ITR) Including Heart Disease, Strokes, Cancer, Diabetes Mellitus, Obesity, High Blood Pressure, & Priongenic Diseases Including Cardiac Amyloidosis: Documents 18, 19, 21, 33, 37, 49, 271, 272, 296, 297, 298, 299, 300, 302, 303, 306, 340, 341, 344, 345, 346, 361, 367, 371, 372, 373, 374, 375, 376, 377, 378, 379, 380, 381, 382, 383, 385, 386, 387, 388, 389, 390, 391, 392, 393, 396, 397, 398, 399, 400, 401, 402, 403, 406, 407, 417, 418, 419, 431, 432, 434, 435, 436, 437, 438, 439, 441, 442, 445, 446, 458, 478, 483, 487, 497, 500, 506, 509, 514.
 
Treatment Information & Immunity: Documents 40, 67, 68,
69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142
, 151, 152, 161, 162, 168, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 183, 186, 187, 205, 206, 207, 208, 211, 216, 217, 223, 232, 235, 236, 237, 238, 239, 240, 241, 244, 245, 246, 247, 248, 249, 257, 258, 259, 260, 261, 262, 266, 267, 269, 271, 272, 276, 277, 280, 281, 285, 288, 289, 290, 291, 292, 311, 317, 319, 321, 332, 339, 348, 352, 365, 367, 369, 370, 372, 373, 379, 382, 384, 385, 386, 387, 389, 390, 391, 392, 397, 398, 402, 409, 418, 420, 422, 423, 424, 428, 429, 430, 440, 449, 480, 481, 500, 508.
 
Gain-of-Function (With HIV-gp120; PRRA & Prion-like Domain): Documents 7, 9, 14, 15, 16, 21, 22, 26, 35, 36, 38, 39, 41, 42, 43, 44, 45, 46, 47, 48, 50, 54, 56, 57, 160, 166, 184, 215, 226, 227, 274, 279, 282, 283, 284, 308, 309, 310, 312, 366, 409, 410, 411, 412, 413, 414, 415, 451, 456, 462, 464, 468, 469, 472, 482, 486, 487, 491, 513.

Biological Viral Weapon (Including genetic vaccines): 58, 59, 60, 61, 62, 226, 227, 243, 244, 245, 274, 279, 282, 448, 452, 453, 455, 456, 459, 460, 461, 462, 464, 465, 469, 471, 479, 484, 510, 511, 513.
 
Vaccines and Immunity Issues: Documents 1, 2, 3, 13, 24, 31, 32, 51, 52, 53, 55, 56, 65, 143, 149, 150, 154, 155, 158, 159, 167, 185, 188, 189, 190, 191, 192, 195, 196, 197, 198, 200, 201, 202, 203, 204, 207, 228, 229, 230, 231, 234, 268, 271, 272, 273, 275, 278, 287, 293, 294, 295, 300, 307, 313, 314, 315, 316, 318, 320, 321, 322, 329, 332, 336, 337, 339, 355, 356, 357, 358, 359, 360, 394, 395, 403, 404, 416, 426, 431, 432, 434, 435, 437, 438, 439, 441, 442, 444, 454, 463, 465, 467, 470, 474, 475, 484, 488, 489, 492, 493, 498, 509, 511, 515

Enters Nucleus with DNA (Including CRISPR): Documents 10, 11, 12, 63, 64, 66, 157, 320, 321, 322, 324, 326, 335, 347, 447, 460, 465, 474, 475, 477, 494, 496, 501, 504, 505, 506, 507, 512, 516, 517, 518, 519, 520, 521, 522.
 
Antibody Dependent Enhancement of Virus: Documents 4, 5, 6, 167, 457, 466.

Neurologic - Central Nervous System - Brain: 8, 23, 25, 27, 28, 29, 30, 34, 235, 236, 238, 239, 240, 241, 248, 249, 252, 257, 270, 278, 296, 297, 298, 299, 300, 304, 305, 323, 359, 360, 361, 363, 364, 366, 367, 377, 378, 380, 391, 397, 408, 419, 421, 427, 485, 500.
2. Pfizer EUA document

December 10, 2020

3. Moderna EUA Document

December 17, 2020

7. Prion-like Domains

March 29,, 2020

54. Deleted Wuhan Databases.

February 23, 2021

58. SARS-CoV-2 Is an Unrestricted Bioweapon.

Released April 24, 2021

60. CNN Lies and Misinformation.

September 14, 2020

62. Lethal Deception.

April 22, 2021

72. ACEI & ARBs.

May 8, 2020

73. Anti-virals.

January 27, 2020

74. Masks.

April 6, 2020

80. Toll-like Receptors.

January 1, 2008

82. Mesenchymal Stem Cells.

February 18, 2020

85. Cuban Interferon.

March 13, 2020

93. N-95 Masks.

February 12, 2020

98. Remdesivir.

April 10, 2020

117. Doxycycline.

May 9, 2020

118. Aminoquinolines.

April 7, 2020

131. Janus Kinases.

November 30, 2004

139. Innate Immunity.

June 17, 2014

165. Appendix for # 164.

January 24, 2020

220. Urbani = SHC014.

April 5, 2021

223. E64d Reduces Amyloid.

2011 (Published February 4, 2015)

224. Rs3367 Genome.

November 22, 2013

225. MA15 Genome.

September 26, 2014

227. NTI Paper.

November 2021

239. Cathepsin B & E64d.

September 2, 2015

269. Omicron Reinfection.
September 14, 2022
270. COVID Alzheimers.
September 13, 2022
275. Pfizer Briefing.
June 14-15, 2022
325. H3K4me1.
July 20, 2022
356. Aluminum Questions.
November 25, 2022
364. ITR & Alzheimer's.
November 23, 2022
392. CD147 and Melanoma.
February 25, 2017
400. CD147 & the ITR.
September 29, 2014
406. CD147 and HIV.
November 30, 2012
427. COVID and "Brain Fog".
November 23, 2022
429. Disease Genetics.
October 2, 2014
449. Paxlovid & Lagevrio.
January 20, 2022
451. Baric Patent for Chimeric (GoF) Coronarvirus Spike Proteins.
February 6, 2018
453. Review by EPOCH Times.
February 16, 2023
464. COVID Lab Origins.
February 27, 2023
509. Poly Ethylene Glycol (PEG) Antibodies Compromise PEGylated Lipid-Based Nanoparticles via InflammoThrombotic Response (ITR).
December 7, 2021

© 2021 by Richard M. Fleming, PhD, MD, JD  All rights reserved. 

bottom of page